Summary
28-day mortality reduction
Study Details
Study Design
Multicenter RCT
Indication
Severe sepsis
Intervention
Thymosin alpha-1 1.6 mg SC
Species
Human
Sample Size
361 subjects
Risk of Bias Assessment
Chinese trial
Tags
SourceRCTThymalfasinSepsisChinaEtass
Metrics
Citations
0Evidence QualityN/A
Related PeptideThymalfasin11 papers